Paratek Pharmaceuticals Inc Banner Image

Paratek Pharmaceuticals Inc

  • Ticker PRTK
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Paratek Pharmaceuticals Inc Logo Image
  • 11-50 Employees
  • Based in Boston, Massachusetts
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of antibacterial therapeutics based upon tetracycline chemistry in the United States. Its lead product candidate, omadacycline, is a tetracycline-derived and broad-spectrum antibiotic developed in oral tablet and intravenous formulations for use as a monotherapy antibiotic for acuteMore bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other serious community-acquired bacterial infections.
Paratek Pharmaceuticals Inc

Most Recent Annual Report

Paratek Pharmaceuticals Inc MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Paratek Pharmaceuticals Inc has reached its limit for free report views.

Older/Archived Annual Reports